SeaSpine to Report First Quarter 2022 Financial Results on May 3, 2022

Rhea-AI Summary

SeaSpine Holdings Corporation (NASDAQ: SPNE) announced it will release its first quarter financial results on May 3, 2022, after market close. Management will host a conference call and webcast at 1:30 PM PT / 4:30 PM ET to discuss the results. Interested parties can listen by calling (877) 418-4766 for domestic or (614) 385-1253 for international callers, using Conference ID: 9979866. SeaSpine specializes in surgical solutions for spinal disorders, featuring innovative technologies like FLASH™ Navigation and a robust portfolio of spinal implants.

Positive

• Upcoming release of first quarter financial results could provide insights into growth and performance.
• Management will host a conference call, allowing investors to gain direct updates.

Negative

• None.

CARLSBAD, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release first quarter financial results after the close of trading on Tuesday, May 3, 2022. Members of the Company’s management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET.

Individuals interested in listening to the conference call may do so by dialing (877) 418-4766 for domestic callers or (614) 385-1253 for international callers, using Conference ID: 9979866. To listen to a live webcast, please visit the Investors section of the SeaSpine website at: www.seaspine.com.

About SeaSpine

SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine’s complete procedural solutions feature its market-leading FLASH™ Navigation, a system designed to improve accuracy of screw placement and provide a cost-effective, rapid, radiation-free solution to surgical navigation, and a comprehensive portfolio of spinal implants and orthobiologics to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures on the lumbar, thoracic and cervical spine. With product development expertise in advanced optics, software, orthobiologic sciences and spinal implants, SeaSpine can offer its surgeon customers a complete solution to meet their patients’ evolving clinical needs. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.

Investor Relations Contact
Leigh Salvo
ir@seaspine.com

FAQ

When will SeaSpine release its first quarter financial results?

SeaSpine will release its first quarter financial results after the close of trading on May 3, 2022.

What time is the SeaSpine conference call for first quarter results?

The conference call will begin at 1:30 PM PT / 4:30 PM ET.

How can I listen to the SeaSpine earnings call?

You can listen by calling (877) 418-4766 for domestic callers or (614) 385-1253 for international callers, using Conference ID: 9979866, or by visiting their website.

What is SeaSpine's focus in medical technology?

SeaSpine focuses on surgical solutions for the treatment of spinal disorders, offering technologies such as FLASH™ Navigation and a range of spinal implants.